- Previous Rank447
- Revenues ($M)6878
- Revenue Percent Change19.9
- Profits ($M)115
- Profits Percent Change-70.3
- Assets ($M)21208
- Employees50000
- Market Value — as of March 31, 2017 ($M)18999
The global contract-research firm conducts clinical trials and other activities for pharmaceutical companies.
Company Info
| CEO | Ari Bousbib |
| CEO Title | Chairman, President & Chief Executive Officer |
| Sector | Health Care |
| Industry | Health Care: Pharmacy and Other Services |
| HQ Location | Durham, NC |
| Website | www.quintilesims.com |
| Years on Fortune 500 List | 4 |
| Employees | 50,000 |
Key Financials (Last Fiscal Year)
| Revenues ($M) | $6,878 |
| Profits ($M) | $115 |
| Assets ($M) | $21,208 |
| Total Stockholder Equity ($M) | $8,633 |
| Market Value — as of March 31, 2017 ($M) | $18,999 |
Profit Ratios
| Profit as % of Revenues | 1.7% |
| Profits as % of Assets | 0.5% |
| Profits as % of Stockholder Equity | 1.3% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 0.76 |
| EPS % Change (from 2015) | -75.3% |
| EPS % Change (5 year annual rate) | - |
| EPS % Change (10 year annual rate) | - |
Total Return
| Total Return to Investors (2016) | 10.8% |
| Total Return to Investors (5 year, annualized) | - |
| Total Return to Investors (10 year, annualized) | - |